MPR Weekly Dose 89 - COVID Vaccine Booster Dose; Vaccines Recommended in Pregnancy; Post-Vaccine Myocarditis Study; Moderna Efficacy at 6 Months; Pompe Disease Tx; FDA Denies Roxadustat
MPR Weekly Dose 89 - COVID Vaccine Booster Dose; Vaccines Recommended in Pregnancy; Post-Vaccine Myocarditis Study; Moderna Efficacy at 6 Months; Pompe Disease Tx; FDA Denies Roxadustat

MPR Weekly Dose 89 - COVID Vaccine Booster Dose; Vaccines Recommended in Pregnancy; Post-Vaccine Myocarditis Study; Moderna Efficacy at 6 Months; Pompe Disease Tx; FDA Denies Roxadustat

Nikita

11 min
Knowledge
Lire

Description

<p><span style="font-weight: 400;">Big news on the COVID-19 vaccine booster dose. The CDC issues new recommendations on vaccines. What protection the Moderna vaccine offers after 6 months. A treatment approved for Pompe disease. And the FDA denies an application for a new roxadustat indication.</span></p>

Diffuseur

ReedPeak

ReedPeak

MPR Weekly Dose 89 - COVID Vaccine Booster Dose; Vaccines Recommended in Pregnancy; Post-Vaccine Myocarditis Study; Moderna Efficacy at 6 Months; Pompe Disease Tx; FDA Denies Roxadustat - Listen Free | WowFM